TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
NVCR

Novocure Ltd

Healthcare · Medical Devices

15.00$ -1.5% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Novocure Ltd (NVCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 795 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NVCR
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
291 282 265 257 262 265 303 310 316 340 370 406 444 479 502 529 431 1,052 1,068 1,097 1,120 1,139 1,150 1,163 1,174 1,192 1,174 1,159 1,146 1,146 1,121 1,212 1,222 1,241 1,249 1,246 1,361 804 788 795
271 262 243 236 242 245 283 290 297 321 336 370 407 440 462 488 383 999 1,015 1,046 1,069 1,074 1,081 1,095 1,102 1,112 1,089 1,065 1,048 1,034 1,003 1,093 1,095 1,107 1,089 1,083 1,200 647 632 639
116 100 85 80 82 79 112 114 123 141 152 180 208 177 182 197 234 246 315 349 690 209 191 367 244 115 186 157 155 241 454 168 185 164 127 150 345 103 97 94
236 220 189 184 187 183 216 219 228 246 257 285 313 326 331 347 234 854 864 899 934 938 932 949 970 969 958 941 921 911 870 955 964 960 931 912 1,036 458 442 441
12 16 27 25 29 38 44 49 45 37 53 58 68 88 108 114 122 100 111 108 112 111 118 116 105 112 99 91 88 77 87 65 67 102 119 129 85 115 93 146
24 26 26 25 25 22 20 20 22 23 24 25 24 24 23 26 26 27 28 27 23 24 29 30 27 29 32 33 37 38 42 40 39 35 39 40 39 41 43 42
9.9 9.8 10 9.6 9.4 9.0 8.9 8.9 8.6 8.4 30 31 31 35 35 36 10 11 42 41 41 54 25 57 30 33 36 41 86 – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
133 140 136 139 146 152 197 198 201 228 244 247 253 262 261 261 124 575 695 700 707 729 714 721 729 750 742 743 753 784 762 850 861 881 887 896 1,020 464 457 457
30 37 32 35 41 50 45 45 48 65 71 74 80 86 84 85 95 114 110 116 125 143 128 135 141 159 149 150 157 179 160 169 735 756 743 750 776 223 218 221
96 96 96 97 97 97 149 149 – – 41 43 48 38 44 47 53 6.5 58 59 65 70 59 55 64 74 67 68 77 8.2 76 79 557 566 559 560 561 12 – –
15 18 15 13 14 17 19 20 20 27 30 30 32 37 40 39 42 54 53 57 60 73 69 80 77 85 81 83 80 94 84 90 91 105 95 104 119 122 127 131
96 96 96 97 97 97 149 149 149 149 149 149 149 149 149 150 – 430 560 561 561 562 563 564 565 566 566 567 568 569 570 653 97 97 97 98 195 195 195 196
158 142 129 118 117 114 106 112 115 112 126 159 190 218 242 268 307 477 372 397 413 410 436 442 445 441 432 416 394 362 359 362 361 360 362 349 341 340 331 338
-498 -520 -539 -560 -571 -582 -601 -616 -628 -644 -656 -657 -655 -651 -647 -645 -636 -631 -632 -646 -659 -686 -691 -715 -741 -778 -832 -889 -938 -986 -1,024 -1,058 -1,088 -1,154 -1,188 -1,229 -1,266 -1,290 -1,361 -1,377
86 87 87 88 89 89 90 91 93 93 95 96 108 108 108 108 109 111 103 103 104 104 104 105 105 105 106 106 107 107 107 108 108 108 110 112 112 111 114 116

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?